Literature DB >> 23243283

Telomere length in mantle cell lymphoma.

Billy Michael Chelliah Jebaraj1, Dirk Kienle, André Lechel, Daniel Mertens, Maria Heuberger, German Ott, Andreas Rosenwald, Thomas F E Barth, Peter Möller, Thorsten Zenz, Hartmut Döhner, Stephan Stilgenbauer.   

Abstract

Telomere shortening is of pathogenic and prognostic importance in cancers. In the present study, we analyzed telomere length in 73 mantle cell lymphoma (MCL), 55 chronic lymphocytic leukemia (CLL), and 20 normal B-cell samples using quantitative PCR (Q-PCR) to study its association with disease characteristics and outcome. Telomere length was found to be highly variable in MCL (range, 2.2-13.8 kb; median, 4.3 kb). Telomere dysfunction in MCL was evident from comparison with normal B cells (median, 7.5 kb), but had no significant association with any biologic or clinical feature. This was in contrast to CLL, in which a significant correlation of short telomeres with poor prognostic subgroups was confirmed. There was a trend toward an increased number of genomic aberrations with shortening of telomeres in MCL. No difference in survival was observed between the groups with short and long telomeres, indicating that, as opposed to CLL, telomere length is not of prognostic relevance in MCL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23243283     DOI: 10.1182/blood-2012-08-452649

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.

Authors:  Patricia Dos Santos; Julieta Panero; Virginia Palau Nagore; Carmen Stanganelli; Raimundo F Bezares; Irma Slavutsky
Journal:  Tumour Biol       Date:  2015-05-26

Review 2.  The biology of aging and lymphoma: a complex interplay.

Authors:  Clémentine Sarkozy; Gilles Salles; Claire Falandry
Journal:  Curr Oncol Rep       Date:  2015-07       Impact factor: 5.075

Review 3.  Association between telomere length and survival in cancer patients: a meta-analysis and review of literature.

Authors:  Xinsen Xu; Kai Qu; Qing Pang; Zhixin Wang; Yanyan Zhou; Chang Liu
Journal:  Front Med       Date:  2016-05-16       Impact factor: 4.592

4.  Impact of telomere length on survival in classic and variant hairy cell leukemia.

Authors:  Evgeny Arons; Hong Zhou; Daniel C Edelman; Allison Gomez; Seth M Steinberg; David Petersen; Yonghong Wang; Paul S Meltzer; Robert J Kreitman
Journal:  Leuk Res       Date:  2015-09-24       Impact factor: 3.156

Review 5.  Telomere Length and Hematological Disorders: A Review.

Authors:  Beatriz Maria Dias Nogueira; Caio Bezerra Machado; Raquel Carvalho Montenegro; Maria Elisabete Amaral DE Moraes; Caroline Aquino Moreira-Nunes
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

6.  Telomere Length, TERT, and miRNA Expression.

Authors:  Martha L Slattery; Jennifer S Herrick; Andrew J Pellatt; Roger K Wolff; Lila E Mullany
Journal:  PLoS One       Date:  2016-09-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.